Publications by authors named "Lukas Bunse"

18Publications

TCR validation toward gene therapy for cancer.

Methods Enzymol 2019 6;629:419-441. Epub 2019 Nov 6.

German Cancer Research Center, DKFZ, Heidelberg, Germany; University Hospital Mannheim, Mannheim, Germany; University Hospital Heidelberg, Heidelberg, Germany. Electronic address:

View Article and Find Full Text PDF
June 2020

High-throughput discovery of cancer-targeting TCRs.

Methods Enzymol 2019 6;629:401-417. Epub 2019 Nov 6.

German Cancer Research Center, DKFZ, Heidelberg, Germany; University Hospital Mannheim, Mannheim, Germany; University Hospital Heidelberg, Heidelberg, Germany. Electronic address:

View Article and Find Full Text PDF
June 2020

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.

Curr Opin Oncol 2018 11;30(6):368-374

German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ).

View Article and Find Full Text PDF
November 2018

Vaccine Strategies in Gliomas.

Curr Treat Options Neurol 2018 Mar 28;20(5):11. Epub 2018 Mar 28.

Department of Neurology, Heidelberg Medical Center, University of Heidelberg, INF 400, 69120, Heidelberg, Germany.

View Article and Find Full Text PDF
March 2018

The promises of immunotherapy in gliomas.

Curr Opin Neurol 2017 Dec;30(6):650-658

aDepartment of Neurology, University Hospital Mannheim, Heidelberg University bCCU Neuroimmunology and Brain Tumor Immunology, First Division, German Cancer Research Center (DKFZ) cDepartment of Neurology and National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany.

View Article and Find Full Text PDF
December 2017

Concepts in glioma immunotherapy.

Cancer Immunol Immunother 2016 10 26;65(10):1269-75. Epub 2016 Jul 26.

DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

View Article and Find Full Text PDF
October 2016

Mutant IDH1: An immunotherapeutic target in tumors.

Oncoimmunology 2014 Dec 7;3(12):e974392. Epub 2015 Jan 7.

DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology; German Cancer Research Center ; Heidelberg, Germany ; Department of Neurooncology; University Hospital Heidelberg ; Heidelberg, Germany.

View Article and Find Full Text PDF
December 2014

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.

Glia 2015 Jan 5;63(1):78-90. Epub 2014 Aug 5.

German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.

View Article and Find Full Text PDF
January 2015

A vaccine targeting mutant IDH1 induces antitumour immunity.

Nature 2014 Aug 25;512(7514):324-7. Epub 2014 Jun 25.

1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

View Article and Find Full Text PDF
August 2014

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Proc Natl Acad Sci U S A 2014 Jan 23;111(1):409-14. Epub 2013 Dec 23.

German Cancer Consortium, Clinical Cooperation Units Neurooncology and Neuropathology, Helmholtz Group Experimental Neuroimmunology, Small Animal Imaging Facility, Biostatistics, and Functional Proteome Analysis, German Cancer Research Center, D-69120 Heidelberg, Germany.

View Article and Find Full Text PDF
January 2014